17 results
424B3
LGND
Ligand Pharmaceuticals, Inc. - Ordinary Shares
14 Nov 06
Prospectus supplement
12:00am
and are renewable.
Our drug development programs will require substantial additional future funding which could hurt our operational and financial
424B3
mouf2b9huvex
15 May 06
Prospectus supplement
12:00am
POS AM
63i2j
12 Apr 06
Prospectus update (post-effective amendment)
12:00am
- Prev
- 1
- Next